This test is most useful if any of these apply to you.
Some of the most damaging autoimmune diseases do not announce themselves. They surface as a scattered set of complaints: blood in the urine, a sinus infection that will not heal, numb fingers, a cough that brings up blood. On their own, each looks minor. Together, they can signal that your immune system is attacking the walls of your smallest blood vessels.
This panel looks for the antibodies behind that attack. It measures antineutrophil cytoplasmic antibodies (immune proteins that mistakenly target your own white blood cells, abbreviated ANCA), then sorts any positive result into distinct patterns. Those patterns point toward specific forms of small vessel vasculitis and, just as usefully, toward conditions that only imitate it.
The panel works in two stages from a single blood sample. First, a screen (using a lab technique called indirect immunofluorescence, or IIF) checks whether your blood contains antibodies that stick to white blood cells at all. Many labs still lead with this screen, though updated guidelines increasingly favor starting with the antibody-specific PR3 and MPO tests. A positive screen is a starting point, not an answer. It tells you antibodies are present, but not which ones or what they mean.
That is where the reflex titers come in. When the screen lights up, the lab characterizes the staining and measures how much antibody is present. A cytoplasmic pattern (C-ANCA) usually reflects an antibody against a protein called proteinase 3, or PR3. Over 90% of cytoplasmic staining in vasculitis traces to this target, which is most closely tied to granulomatosis with polyangiitis (GPA), a disease that favors the sinuses, lungs, and kidneys.
A perinuclear pattern (P-ANCA) usually reflects an antibody against myeloperoxidase, or MPO, and points most often toward microscopic polyangiitis (MPA). It is also seen in some cases of eosinophilic granulomatosis with polyangiitis (EGPA), though that disease is more often ANCA-negative than positive. The third bucket, atypical P-ANCA, captures staining that fits neither classic pattern. These antibodies usually target other proteins entirely and more often signal a mimic than true vasculitis.
No single line on this report is a diagnosis. The value is in how the pieces line up, and how strong each signal is.
| Pattern | What It Suggests |
|---|---|
| Cytoplasmic pattern (C-ANCA), high titer | Most suggestive of granulomatosis with polyangiitis, especially with sinus, lung, or kidney findings. A proteinase 3 antibody test sharpens the picture. |
| Perinuclear pattern (P-ANCA), high titer | Points toward microscopic polyangiitis, and in a minority of cases eosinophilic vasculitis (which is more often ANCA-negative). Less specific than the cytoplasmic pattern, so symptoms carry more weight. |
| Atypical P-ANCA, negative for PR3 and MPO | Rarely reflects vasculitis. More often seen in bowel or liver inflammation and other autoimmune conditions. |
| Positive screen, low titer, mild symptoms | Weak evidence. False positives are common when vasculitis is unlikely, so a repeat or antibody-specific test helps. |
Titer height carries weight. Higher antibody levels are more likely to reflect true vasculitis than borderline positives, and accuracy climbs when a pattern is confirmed by an antibody-specific test. In one 5,157-person cohort, the share of people without vasculitis correctly cleared rose to 96.8% when positives were restricted to classic patterns, and pairing a classic pattern with a positive antibody test pushed that to 99.6%.
A positive result is a prompt to investigate, not a verdict. Because these antibodies can appear without disease, a positive screen alone should never lead to treatment. If you have signs of organ involvement, the workup moves quickly: a urine test for blood and protein, kidney function labs, and chest imaging help locate where vessels are inflamed. A tissue biopsy remains the most reliable way to confirm vasculitis and is often the deciding step. Bring any positive result to a rheumatologist or nephrologist.
If you already carry a vasculitis diagnosis, the panel has a second role: tracking. Antibody levels tend to fall with successful treatment and can rise before a flare, though the link is imperfect. Serial monitoring predicts relapse with only modest accuracy, roughly 70% sensitivity and 66% specificity, so a rising titer is a reason to look closer, not to change treatment on its own.
The biggest trap with this panel is testing when vasculitis is unlikely. Ordered broadly, a positive result is far more often a false alarm than a real finding. The test earns its value when symptoms already point toward inflamed blood vessels.
A few confounders can distort several parts of the panel at once. Antinuclear antibodies (a separate family of autoimmune proteins, abbreviated ANA) can create a false perinuclear pattern on the screen. Certain drugs, including some thyroid medications and hydralazine, can trigger genuine antibodies without classic disease. Chronic infections and inflammatory bowel disease (IBD) also produce positive results, usually of the atypical type.
ANCA Screen with Reflex is best interpreted alongside these tests.